X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (131) 131
index medicus (131) 131
oncology (102) 102
male (87) 87
middle aged (72) 72
cancer (67) 67
aged (64) 64
female (59) 59
article (43) 43
carcinoma, renal cell - drug therapy (43) 43
kidney neoplasms - drug therapy (40) 40
survival (40) 40
care and treatment (37) 37
carcinoma, renal cell (36) 36
adult (35) 35
hematology, oncology and palliative medicine (35) 35
prognosis (32) 32
risk factors (32) 32
urology & nephrology (32) 32
metastasis (31) 31
renal cell carcinoma (30) 30
kidney neoplasms - pathology (28) 28
sunitinib (28) 28
interferon-alpha (27) 27
urology (27) 27
treatment outcome (26) 26
aged, 80 and over (25) 25
disease-free survival (25) 25
prostate cancer (25) 25
abridged index medicus (24) 24
antineoplastic agents - therapeutic use (24) 24
health aspects (24) 24
analysis (23) 23
carcinoma (22) 22
carcinoma, renal cell - pathology (22) 22
kidney cancer (22) 22
carcinoma, renal cell - genetics (21) 21
vascular endothelial growth factor (20) 20
risk (19) 19
neoplasm metastasis (18) 18
antineoplastic agents - adverse effects (17) 17
bevacizumab (17) 17
chemotherapy (17) 17
kidney neoplasms - genetics (17) 17
research (17) 17
sorafenib (17) 17
everolimus (16) 16
therapy (16) 16
carcinoma, renal cell - mortality (15) 15
carcinoma, renal cell - secondary (15) 15
clear cell-type renal cell carcinoma (15) 15
men (15) 15
mutation (15) 15
neoplasm staging (15) 15
patients (15) 15
retrospective studies (15) 15
tumors (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
double-blind (14) 14
immunotherapy (14) 14
medical colleges (14) 14
targeted therapy (14) 14
usage (14) 14
diagnosis (13) 13
expression (13) 13
kidney neoplasms - mortality (13) 13
neoplasms - drug therapy (13) 13
risk assessment (13) 13
survival analysis (13) 13
gene expression (12) 12
kaplan-meier estimate (12) 12
metastases (12) 12
neoplasm grading (12) 12
prostatic neoplasms - pathology (12) 12
prostatic neoplasms - therapy (12) 12
radical prostatectomy (12) 12
survival rate (12) 12
trial (12) 12
antineoplastic agents (11) 11
clinical trials as topic (11) 11
drug therapy (11) 11
genomics (11) 11
hematology (11) 11
incidence (11) 11
medicine & public health (11) 11
pazopanib (11) 11
protein kinase inhibitors - therapeutic use (11) 11
randomized controlled trials as topic (11) 11
seer program (11) 11
antimitotic agents (10) 10
endothelial growth-factor (10) 10
medical prognosis (10) 10
medicine, general & internal (10) 10
outcomes (10) 10
patient outcomes (10) 10
proportional hazards models (10) 10
radiotherapy (10) 10
animals (9) 9
cancer therapies (9) 9
cell biology (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 01/2014, Volume 32, Issue 1, pp. 5 - 15
This review provides a broad overview of emerging data that provide hope that rational precision medicine for metastatic renal cell carcinoma (RCC) may be... 
Biomarkers | Renal cell carcinoma | Prognostic | Predictive
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 01/2014, Volume 32, Issue 1, p. 5
This review provides a broad overview of emerging data that provide hope that rational precision medicine for metastatic renal cell carcinoma (RCC) may be... 
Biological products industry | Metastasis
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 293 - 300
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 917 - 927
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 426 - 435
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10032, pp. 2008 - 2016
Journal Article
by Thorsson, Vésteinn and Gibbs, David L and Brown, Scott D and Wolf, Denise and Bortone, Dante S and Ou Yang, Tai-Hsien and Porta-Pardo, Eduard and Gao, Galen F and Plaisier, Christopher L and Eddy, James A and Ziv, Elad and Culhane, Aedin C and Paull, Evan O and Sivakumar, I.K. Ashok and Gentles, Andrew J and Malhotra, Raunaq and Farshidfar, Farshad and Colaprico, Antonio and Parker, Joel S and Mose, Lisle E and Vo, Nam Sy and Liu, Jianfang and Liu, Yuexin and Rader, Janet and Dhankani, Varsha and Reynolds, Sheila M and Bowlby, Reanne and Califano, Andrea and Cherniack, Andrew D and Anastassiou, Dimitris and Bedognetti, Davide and Mokrab, Younes and Newman, Aaron M and Rao, Arvind and Chen, Ken and Krasnitz, Alexander and Hu, Hai and Malta, Tathiane M and Noushmehr, Houtan and Pedamallu, Chandra Sekhar and Bullman, Susan and Ojesina, Akinyemi I and Lamb, Andrew and Zhou, Wanding and Shen, Hui and Choueiri, Toni K and Weinstein, John N and Guinney, Justin and Saltz, Joel and Holt, Robert A and Rabkin, Charles S and Caesar-Johnson, Samantha J and Demchok, John A and Felau, Ina and Kasapi, Melpomeni and Ferguson, Martin L and Hutter, Carolyn M and Sofia, Heidi J and Tarnuzzer, Roy and Wang, Zhining and Yang, Liming and Zenklusen, Jean C and Zhang, Jiashan (Julia) and Chudamani, Sudha and Liu, Jia and Lolla, Laxmi and Naresh, Rashi and Pihl, Todd and Sun, Qiang and Wan, Yunhu and Wu, Ye and Cho, Juok and DeFreitas, Timothy and Frazer, Scott and Gehlenborg, Nils and Getz, Gad and Heiman, David I and Kim, Jaegil and Lawrence, Michael S and Lin, Pei and Meier, Sam and Noble, Michael S and Saksena, Gordon and Voet, Doug and Zhang, Hailei and Bernard, Brady and Chambwe, Nyasha and Dhankani, Varsha and Knijnenburg, Theo and Kramer, Roger and Leinonen, Kalle and Liu, Yuexin and Miller, Michael and Reynolds, Sheila and Shmulevich, Ilya and Thorsson, Vesteinn and Zhang, Wei and Akbani, Rehan and Broom, Bradley M and Hegde, Apurva M and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
Immunity, ISSN 1074-7613, 04/2018, Volume 48, Issue 4, pp. 812 - 830.e14
We performed an extensive immunogenomic analysis of more than 10,000 tumors comprising 33 diverse cancer types by utilizing data compiled by TCGA. Across... 
tumor immunology | immunotherapy | cancer genomics | integrative network analysis | immuno-oncology | tumor microenvironment | immune subtypes | immunomodulatory | Immunology | Infectious Diseases | Immunology and Allergy | GENOMIC ANALYSES | INFORMATION | T-CELL-RECEPTOR | REGULATORY NETWORK | CLASSIFICATION | IMMUNOLOGY | SEQUENCING DATA | SOMATIC MUTATIONS | COMPREHENSIVE ANALYSIS | PREDICTION | REVEALS | Transforming Growth Factor beta - immunology | Prognosis | Humans | Middle Aged | Th1-Th2 Balance - physiology | Male | Neoplasms - classification | Wound Healing - immunology | Young Adult | Transforming Growth Factor beta - genetics | Neoplasms - genetics | Neoplasms - immunology | Interferon-gamma - immunology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Interferon-gamma - genetics | Wound Healing - genetics | Genomics - methods | Child | Macrophages - immunology | Cell proliferation | Cluster analysis | Transcription | Copy number | p53 Protein | Lung cancer | Genomics | Aneuploidy | Lymphocytes T | Genomes | Cell interactions | Macrophages | Immunotherapy | DNA methylation | miRNA | Deoxyribonucleic acid--DNA | Immune system | Medical research | Wound healing | Immunomodulation | Stockholders | Inflammation | T cell receptors | Communications networks | Gene expression | White blood cells | Inventors | Medical prognosis | γ-Interferon | Mutation | Cancer | Tumors | Immune Subtypes | Integrative Network Analysis | Cancer Genomics | Immuno-oncology | Tumor immunology
Journal Article